Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: June 13, 2023
The
relentless
evolution
of
SARS-CoV-2
poses
a
significant
threat
to
public
health,
as
it
adapts
immune
pressure
from
vaccines
and
natural
infections.
Gaining
insights
into
potential
antigenic
changes
is
critical
but
challenging
due
the
vast
sequence
space.
Here,
we
introduce
Machine
Learning-guided
Antigenic
Evolution
Prediction
(MLAEP),
which
combines
structure
modeling,
multi-task
learning,
genetic
algorithms
predict
viral
fitness
landscape
explore
via
in
silico
directed
evolution.
By
analyzing
existing
variants,
MLAEP
accurately
infers
variant
order
along
evolutionary
trajectories,
correlating
with
corresponding
sampling
time.
Our
approach
identified
novel
mutations
immunocompromised
COVID-19
patients
emerging
variants
like
XBB1.5.
Additionally,
predictions
were
validated
through
vitro
neutralizing
antibody
binding
assays,
demonstrating
that
predicted
exhibited
enhanced
evasion.
profiling
predicting
changes,
aids
vaccine
development
enhances
preparedness
against
future
variants.
Nature,
Journal Year:
2023,
Volume and Issue:
622(7984), P. 818 - 825
Published: Oct. 11, 2023
Abstract
Effective
pandemic
preparedness
relies
on
anticipating
viral
mutations
that
are
able
to
evade
host
immune
responses
facilitate
vaccine
and
therapeutic
design.
However,
current
strategies
for
evolution
prediction
not
available
early
in
a
pandemic—experimental
approaches
require
polyclonal
antibodies
test
against
1–16
,
existing
computational
methods
draw
heavily
from
strain
prevalence
make
reliable
predictions
of
variants
concern
17–19
.
To
address
this,
we
developed
EVEscape,
generalizable
modular
framework
combines
fitness
deep
learning
model
historical
sequences
with
biophysical
structural
information.
EVEscape
quantifies
the
escape
potential
at
scale
has
advantage
being
applicable
before
surveillance
sequencing,
experimental
scans
or
three-dimensional
structures
antibody
complexes
available.
We
demonstrate
trained
2020,
is
as
accurate
high-throughput
variation
SARS-CoV-2
other
viruses
including
influenza,
HIV
understudied
such
Lassa
Nipah.
provide
continually
revised
scores
all
strains
predict
probable
further
forecast
emerging
tool
continuing
development
(
evescape.org
).
Virus Evolution,
Journal Year:
2023,
Volume and Issue:
9(2)
Published: July 1, 2023
Knowledge
of
the
fitness
effects
mutations
to
SARS-CoV-2
can
inform
assessment
new
variants,
design
therapeutics
resistant
escape,
and
understanding
functions
viral
proteins.
However,
experimentally
measuring
is
challenging:
we
lack
tractable
lab
assays
for
many
proteins,
comprehensive
deep
mutational
scanning
has
been
applied
only
two
Here,
develop
an
approach
that
leverages
millions
publicly
available
sequences
estimate
mutations.
We
first
calculate
how
independent
occurrences
each
mutation
are
expected
be
observed
along
phylogeny
in
absence
selection.
then
compare
these
observations
actual
effect
mutation.
These
estimates
correlate
well
with
measurements.
For
most
genes,
synonymous
nearly
neutral,
stop-codon
deleterious,
amino
acid
have
a
range
effects.
some
accessory
proteins
under
little
no
provide
interactive
visualizations
all
(https://jbloomlab.github.io/SARS2-mut-fitness/).
The
framework
describe
applicable
any
virus
which
number
sufficiently
large
neutral
observed.
PLoS Pathogens,
Journal Year:
2023,
Volume and Issue:
19(12), P. e1011868 - e1011868
Published: Dec. 20, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
XBB
lineages
have
achieved
dominance
worldwide
and
keep
on
evolving.
Convergent
evolution
of
the
receptor-binding
domain
(RBD)
L455F
F456L
is
observed,
resulting
in
variants
with
substantial
growth
advantages,
such
as
EG.5,
FL.1.5.1,
XBB.1.5.70,
HK.3.
Here,
we
show
that
neutralizing
antibody
(NAb)
evasion
drives
convergent
F456L,
while
epistatic
shift
caused
by
enables
subsequent
convergence
through
ACE2
binding
enhancement
further
immune
evasion.
evade
RBD-targeting
Class
1
public
NAbs,
reducing
neutralization
efficacy
breakthrough
infection
(BTI)
reinfection
convalescent
plasma.
Importantly,
single
substitution
significantly
dampens
receptor
binding;
however,
combination
forms
an
adjacent
residue
flipping,
which
leads
to
enhanced
NAbs
resistance
affinity.
The
perturbed
mode
exceptional
NAb
evasion,
revealed
structural
analyses.
Our
results
indicate
flexibility
contributed
epistasis
cannot
be
underestimated,
potential
SARS-CoV-2
RBD
remains
high.
Nature,
Journal Year:
2023,
Volume and Issue:
618(7965), P. 590 - 597
Published: May 31, 2023
Rapidly
evolving
influenza
A
viruses
(IAVs)
and
B
(IBVs)
are
major
causes
of
recurrent
lower
respiratory
tract
infections.
Current
vaccines
elicit
antibodies
predominantly
to
the
highly
variable
head
region
haemagglutinin
their
effectiveness
is
limited
by
viral
drift1
suboptimal
immune
responses2.
Here
we
describe
a
neuraminidase-targeting
monoclonal
antibody,
FNI9,
that
potently
inhibits
enzymatic
activity
all
group
1
2
IAVs,
as
well
Victoria/2/87-like,
Yamagata/16/88-like
ancestral
IBVs.
FNI9
broadly
neutralizes
seasonal
IAVs
IBVs,
including
immune-evading
H3N2
strains
bearing
an
N-glycan
at
position
245,
shows
synergistic
when
combined
with
anti-haemagglutinin
stem-directed
antibodies.
Structural
analysis
reveals
D107
in
heavy
chain
complementarity-determinant
3
mimics
interaction
sialic
acid
carboxyl
three
conserved
arginine
residues
(R118,
R292
R371)
neuraminidase
catalytic
site.
demonstrates
potent
prophylactic
against
lethal
IAV
IBV
infections
mice.
The
unprecedented
breadth
potency
antibody
supports
its
development
for
prevention
illness
pandemic
viruses.
The
Omicron
BA.1
variant
of
SARS-CoV-2
escapes
convalescent
sera
and
monoclonal
antibodies
that
are
effective
against
earlier
strains
the
virus.
This
immune
evasion
is
largely
a
consequence
mutations
in
receptor
binding
domain
(RBD),
major
antigenic
target
SARS-CoV-2.
Previous
studies
have
identified
several
key
RBD
leading
to
escape
from
most
antibodies.
However,
little
known
about
how
these
interact
with
each
other
RBD.
Here,
we
systematically
map
interactions
by
measuring
affinity
all
possible
combinations
15
(2
=32,768
genotypes)
4
(LY-CoV016,
LY-CoV555,
REGN10987,
S309)
distinct
epitopes.
We
find
can
lose
diverse
acquiring
few
large-effect
reduce
others
through
small-effect
mutations.
our
results
also
reveal
alternative
pathways
antibody
does
not
include
every
mutation.
Moreover,
epistatic
shown
constrain
decline
S309
but
only
modestly
shape
landscapes
Together
previous
work
on
ACE2
landscape,
suggest
mediated
groups
mutations,
whose
deleterious
effects
compensated
another
group
(most
notably
Q498R
N501Y).
Science,
Journal Year:
2024,
Volume and Issue:
385(6704), P. 46 - 53
Published: July 4, 2024
Large
language
models
trained
on
sequence
information
alone
can
learn
high-level
principles
of
protein
design.
However,
beyond
sequence,
the
three-dimensional
structures
proteins
determine
their
specific
function,
activity,
and
evolvability.
Here,
we
show
that
a
general
model
augmented
with
structure
backbone
coordinates
guide
evolution
for
diverse
without
need
to
individual
functional
tasks.
We
also
demonstrate
ESM-IF1,
which
was
only
single-chain
structures,
be
extended
engineer
complexes.
Using
this
approach,
screened
about
30
variants
two
therapeutic
clinical
antibodies
used
treat
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection.
achieved
up
25-fold
improvement
in
neutralization
37-fold
affinity
against
antibody-escaped
viral
concern
BQ.1.1
XBB.1.5,
respectively.
These
findings
highlight
advantage
integrating
structural
identify
efficient
trajectories
requiring
any
task-specific
training
data.
Protein & Cell,
Journal Year:
2024,
Volume and Issue:
15(6), P. 403 - 418
Published: March 4, 2024
Intensive
selection
pressure
constrains
the
evolutionary
trajectory
of
SARS-CoV-2
genomes
and
results
in
various
novel
variants
with
distinct
mutation
profiles.
Point
mutations,
particularly
those
within
receptor
binding
domain
(RBD)
spike
(S)
protein,
lead
to
functional
alteration
both
engagement
monoclonal
antibody
(mAb)
recognition.
Here,
we
review
data
RBD
point
mutations
possessed
by
major
discuss
their
individual
effects
on
ACE2
affinity
immune
evasion.
Many
single
amino
acid
substitutions
epitopes
crucial
for
evasion
capacity
may
conversely
weaken
affinity.
However,
this
weakened
effect
could
be
largely
compensated
specific
epistatic
such
as
N501Y,
thus
maintaining
overall
protein
all
variants.
The
predominant
direction
evolution
lies
neither
promoting
nor
evading
mAb
neutralization
but
a
delicate
balance
between
these
two
dimensions.
Together,
interprets
how
efficiently
resist
meanwhile
is
maintained,
emphasizing
significance
comprehensive
assessment
mutations.